Esperion Therapeutics, Inc. (LON:0IIM)
London flag London · Delayed Price · Currency is GBP · Price in USD
1.185
+0.106 (9.80%)
At close: Jun 5, 2025

Esperion Therapeutics Market Cap

Esperion Therapeutics has a market cap or net worth of 169.13 million as of June 6, 2025. Its market cap has decreased by -54.27% in one year.

Market Cap
169.13M
Enterprise Value
521.76M
Revenue
200.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.19

Market Cap Chart

Since June 26, 2013, Esperion Therapeutics's market cap has increased from 137.93M to 169.13M, an increase of 22.62%. That is a compound annual growth rate of 1.72%.

History

DateMarket Cap% Change
Jun 5, 2025169.13M-51.15%
Dec 31, 2024346.25M29.71%
Dec 29, 2023266.94M-29.93%
Dec 30, 2022380.99M68.53%
Dec 31, 2021226.06M-57.42%
Dec 31, 2020530.87M-56.85%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 165.92B
GSK plc 61.28B
Haleon 36.46B
Smith & Nephew 9.77B
ConvaTec Group 6.03B
Hikma Pharmaceuticals 4.64B
HUTCHMED (China) 1.91B
Genus 1.30B
Market Cap Rankings